US3137451015 - REIT

**FRT** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 131 industry peers in the **Diversified REITs** industry. **FRT** has an excellent profitability rating, but there are concerns on its financial health. **FRT** has a expensive valuation and it also scores bad on growth.

In the past year **FRT** had a positive cash flow from operations.

Each year in the past 5 years **FRT** has been profitable.

With an excellent **Return On Assets** value of **3.37%**, **FRT** belongs to the best of the industry, outperforming **83.59%** of the companies in the same industry.

With an excellent **Return On Invested Capital** value of **3.88%**, **FRT** belongs to the best of the industry, outperforming **81.25%** of the companies in the same industry.

The last **Return On Invested Capital** (**3.88%**) for **FRT** is above the 3 year average (**3.24%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.37% | ||

ROE | 9.69% | ||

ROIC | 3.88% |

ROA(3y)3.16%

ROA(5y)3.65%

ROE(3y)9.16%

ROE(5y)10.2%

ROIC(3y)3.24%

ROIC(5y)3.74%

With a decent **Profit Margin** value of **24.92%**, **FRT** is doing good in the industry, outperforming **77.34%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **FRT** has declined.

Looking at the **Gross Margin**, with a value of **67.57%**, **FRT** is in line with its industry, outperforming **48.44%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 34.56% | ||

PM (TTM) | 24.92% | ||

GM | 67.57% |

OM growth 3Y-3.79%

OM growth 5Y-2.74%

PM growth 3Y-1.69%

PM growth 5Y0.93%

GM growth 3Y-0.63%

GM growth 5Y-0.41%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **FRT** is destroying value.

Compared to 1 year ago, **FRT** has more shares outstanding

Compared to 5 years ago, **FRT** has more shares outstanding

The debt/assets ratio for **FRT** has been reduced compared to a year ago.

Based on the Altman-Z score of **1.02**, we must say that **FRT** is in the distress zone and has some risk of bankruptcy.

With a decent **Altman-Z score** value of **1.02**, **FRT** is doing good in the industry, outperforming **76.56%** of the companies in the same industry.

The Debt to FCF ratio of **FRT** is **39.67**, which is on the high side as it means it would take **FRT**, **39.67** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **1.57** is on the high side and indicates that **FRT** has dependencies on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **1.57**, **FRT** is doing worse than **68.75%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.57 | ||

Debt/FCF | 39.67 | ||

Altman-Z | 1.02 |

ROIC/WACC0.55

WACC7.1%

A Current Ratio of **1.36** indicates that **FRT** should not have too much problems paying its short term obligations.

A Quick Ratio of **1.36** indicates that **FRT** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.36 | ||

Quick Ratio | 1.36 |

The earnings per share for **FRT** have decreased strongly by **-26.96%** in the last year.

The **Revenue** has been growing slightly by **4.62%** on average over the past years.

EPS 1Y (TTM)-26.96%

EPS 3Y0.58%

EPS 5Y2.44%

EPS growth Q2Q-64.55%

Revenue 1Y (TTM)6.86%

Revenue growth 3Y4.71%

Revenue growth 5Y4.62%

Revenue growth Q2Q4.79%

The **Earnings Per Share** is expected to decrease by **-4.44%** on average over the next years.

EPS Next Y-42.73%

EPS Next 2Y-21.52%

EPS Next 3Y-11.8%

EPS Next 5Y-4.44%

Revenue Next Year5.84%

Revenue Next 2Y5.24%

Revenue Next 3Y5.61%

Revenue Next 5Y5.6%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

The **Price/Earnings** ratio is **28.81**, which means the current valuation is very expensive for **FRT**.

64.84% of the companies in the same industry are more expensive than **FRT**, based on the **Price/Earnings** ratio.

The average S&P500 **Price/Earnings** ratio is at **24.97**. **FRT** is around the same levels.

A **Price/Forward Earnings** ratio of **34.46** indicates a quite expensive valuation of **FRT**.

Based on the **Price/Forward Earnings** ratio, **FRT** is valued a bit cheaper than the industry average as 67.97% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 28.81 | ||

Fwd PE | 34.46 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 71.03 | ||

EV/EBITDA | 17.71 |

A cheap valuation may be justified as **FRT**'s earnings are expected to decrease with **-11.80%** in the coming years.

PEG (NY)N/A

PEG (5Y)11.82

EPS Next 2Y-21.52%

EPS Next 3Y-11.8%

With a **Yearly Dividend Yield** of **4.56%**, **FRT** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **6.40**, **FRT** is paying slightly less dividend.

Compared to an average S&P500 **Dividend Yield** of **2.58**, **FRT** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 4.56% |

The dividend of **FRT** has a limited annual growth rate of **2.18%**.

Dividend Growth(5Y)2.18%

Div Incr Years20

Div Non Decr Years20

The **Dividend Rate** of **FRT** has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.

DP128.22%

EPS Next 2Y-21.52%

EPS Next 3Y-11.8%

**FEDERAL REALTY INVS TRUST**

NYSE:FRT (12/8/2023, 7:04:00 PM)

After market: 99.12 0 (0%)**99.12**

**+0.11 (+0.11%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap8.09B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 4.56% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 28.81 | ||

Fwd PE | 34.46 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)11.82

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.37% | ||

ROE | 9.69% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 34.56% | ||

PM (TTM) | 24.92% | ||

GM | 67.57% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.14

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.57 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.36 | ||

Quick Ratio | 1.36 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-26.96%

EPS 3Y0.58%

EPS 5Y

EPS growth Q2Q

EPS Next Y-42.73%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)6.86%

Revenue growth 3Y4.71%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y